Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

CD70 Deregulation in Follicular Lymphoma at Diagnosis Is Associated with Relapse and Opens New Avenues for Dual CD19-CD70 CAR-T Therapy

Blood (2024) 144 (Supplement 1): 333.

https://doi.org/10.1182/blood-2024-199167

Published: 2024

Journal Articles

From in silico to in Vitro to In Vivo : Increasing Megakaryocytes to Treat Thrombocytopenia

Alejandra Macias, Mauricio Cortes, Na An, Na Li, Timothy Fulton, Allison Simpson, Samuel Miller, Sunny Sun, Doris Fu, Juan Garcia, Satya Medicherla, Scott Steelman, Atli Thorarensen, Matthew Goddeeris, Sriram Krishnamoorthy

Blood (2023) 142 (Supplement 1): 5580.

https://doi.org/10.1182/blood-2023-190250

Published: 2023

Journal Articles

Chimeric Antigen Receptor T Cell Therapies Clinical Trials in Pediatric Oncology: A Retrospective Analysis from Clinicaltrials.Gov

Fabio Samir Vargas Cely, David A. Martinez, Juan Garcia Robledo, Pedro Franco-Fuquen, Rhea Hans, Eider Moreno-Cortes, Daniela A Castro Martinez, Januario E. Castro

Blood (2023) 142 (Supplement 1): 6890.

https://doi.org/10.1182/blood-2023-191044

Published: 2023

Journal Articles

HCT.CI in Autologous Stem Cell Transplantation. Predicting Early and Late Transplant Related Mortality

Blood (2016) 128 (22): 3449.

https://doi.org/10.1182/blood.V128.22.3449.3449

Published: 2016

Journal Articles

Is Not Age, But Comorbidities. Allogeneic Hematopoietic Stem Cell Transplantation In Patients Older Than 50 Years In Argentina

Mariano Berro, MD, Juan Garcia, MD, Ana Basquiera, MD, Maria Marta Rivas, MD, Maria Cecilia Foncuberta, MD, Ruben Burgos, MD, Gregorio Jaimovich, Vera Milovic, Juliana Martinez Rolon, MD, Guillermina Remaggi, PhD, Jorge Arbelbide, MD, Jorge H Milone, Sebastian Yantorno, Gustavo Jarchum, MD, Maria Sol Jarchum, G Caeiro, Gustavo Daniel Kusminsky, MD

Blood (2013) 122 (21): 5467.

https://doi.org/10.1182/blood.V122.21.5467.5467

Published: 2013

Journal Articles

Allogeneic Stem Cell Transplantation With Reduced Intensity Conditioning Regimen In Patients With Relapsed Hodgkin´s Lymphoma

Maria Marta Rivas, MD, Mariano Berro, MD, Sebastian Yantorno, MD, Maria Virginia Prates, MD, Jorge H Milone, Ana Lisa Basquiera, Adriana Berreta, MD, Juan Garcia, MD, Guillermina Remaggi, MD, Juliana Martinez Rolon, MD, Jorge Arbelbide, MD, Monica Makiya, MD, Eduardo Dibar, Alejandro Requejo, MD, Leonardo Julio Feldman, Sr., MD, Vera Milovic, Maria Cecilia Foncuberta, MD, Rubén Burgos, MD, Gustavo Daniel Kusminsky, MD

Blood (2013) 122 (21): 5511.

https://doi.org/10.1182/blood.V122.21.5511.5511

Published: 2013

Journal Articles

Long-Term Disease-Free Survival in Patients with Relapsed/Refractory Follicular Lymphoma After Autologous Stem Cell Trasplantation

Pablo A Garcia, Guillermina Remaggi, PhD, Diego A de Goycoechea, Sebastian Yantorno, Maria Marta Rivas, MS, PhD, Ana Basquiera, MD, Maria Virginia Prates, MD, Soledad Molnar, Maria L Rizzi, Gustavo Jarchum, MD, Gustavo Milone, Jorge H Milone, Gustavo Daniel Kusminsky, MD, Miguel Arturo Pavlovsky, Juliana Martinez Rolon, MD, Juan Garcia, MD

Blood (2012) 120 (21): 2031.

https://doi.org/10.1182/blood.V120.21.2031.2031

Published: 2012

Journal Articles

Long-Term Experience with Allogeneic Bone Marrow Transplant (BMT) in Chronic Myeloid Leukemia

Alicia Inés Enrico, MD, Ana Basquiera, MD, Juan Jose Napal, MD, Ana Gabriela Sturich, MD, Maria Virginia Prates, MD, Juan Garcia, MD, Sebastian Yantorno, MD, Santiago Milone, Alicia Navickas, MD, Jorge Milone, MD

Blood (2011) 118 (21): 4582.

https://doi.org/10.1182/blood.V118.21.4582.4582

Published: 2011

Journal Articles

Argentine Registry of Hematologic Disease (RAEH) Chronics Myeloid Leukemia

Alicia Inés Enrico, MD, Beatriz Moiraghi, MD, Graciela Klein, MD, Maria del Rosario Cabrejo, MD, Renee Crisp, MD, Georgina Bendek, MD, Mariana Gil, MD, Juan Garcia, MD, Abel Alzueta, MD, Alejandro Cicchetti, MD, Francisca Rojas, MD, Mariel Perez, MD, Ruben Burgos, MD, Raquel Bengió, MD

Blood (2011) 118 (21): 4455.

https://doi.org/10.1182/blood.V118.21.4455.4455

Published: 2011

Journal Articles

Overall Survival by Prognosis Score in High-Risk Myelodysplastic Syndromes (MDS) Patients Receiving Decitabine Treatment: Results From Clinical Experience

Marcelo Iastrebner, MD, Jun Ho Jang, MD, Kihyun Kim, MD, Chul W. Jung, MD, PhD, Elsa Nucifora, MD, Federico Sackmann, Sergio Orlando, MD, Graciela Klein, MD, Juan Garcia, MD, Carolina Belli, PhD, Luis Quiroga, MD, Fernando Santini, MD, Haydee i Bernard, MD, Lino Salvatierra, MD, Gustavo Taborda, MD, Raquel Bengió, MD

Blood (2011) 118 (21): 5024.

https://doi.org/10.1182/blood.V118.21.5024.5024

Published: 2011

Journal Articles

Efficacy Analysis From Phase I Study of Lorvotuzumab Mertansine (IMGN901), Used as Monotherapy, In Patients with Heavily Pre-Treated CD56-Positive Multiple Myeloma - A Preliminary Efficacy Analysis

Asher Chanan-Khan, MD, Jeffrey L Wolf, MD, Juan Garcia, MD, Mecide Gharibo, MD, Sundar Jagannath, MD, Debbie Manfredi, Taimur Sher, MD, Cindi Martin, Sybil H Zildjian, MPH, James O'Leary, MD, Robert Vescio, MD

Blood (2010) 116 (21): 1962.

https://doi.org/10.1182/blood.V116.21.1962.1962

Published: 2010

Journal Articles

Applicability of a New Prognostic Scoring System in Myelodysplastic Syndromes. MDS Study Group of Hematology.

Gabriela Flores, Maria Isabel Santos, MD, Graciela Alfonso, MD, Maria Cabrejo, Maria Virginia Prates, Marcelo Iastrebner, MD, Dorotea Beatriz Fantl, MD, Jorge Arbelbide, Reinaldo Campestri, MD, Diana Penchasky, MD, Paula Cardenas, MD, Federico Sackmann, Juan Garcia, MD, Elsa Nucifora, MD, Ana Basquiera, Astrid Pavlovsky, Miguel Arturo Pavlovsky, Isolda Fernandez, Susana Viñuales, MD

Blood (2009) 114 (22): 4838.

https://doi.org/10.1182/blood.V114.22.4838.4838

Published: 2009

Journal Articles

Decitabine Activity in Myelodysplastic Syndromes. International Cooperative Multi-Center Study.

Marcelo Iastrebner, MD, Jun Ho Jang, Elsa Nucifora, MD, Kihyun Kim, M.D., Federico Sackmann, Dong Hwan (Dennis) Kim, Sergio Orlando, Chul Won Jung, Ana Basquiera, MD, Raquel Bengio, Luis Quiroga, MD, Graciela Klein, MD, Juan Garcia, MD, Jorge Arbelbide, Astrid Pavlovsky, Maria Virginia Prates

Blood (2009) 114 (22): 3804.

https://doi.org/10.1182/blood.V114.22.3804.3804

Published: 2009

Journal Articles

KIR-Ligand Incompatibility in the Graft-Versus-Host Direction Is Associated with Better Outcomes after Unrelated Cord Blood Stem Cell Transplantation for Acute Leukemia in Complete Remission

Blood (2008) 112 (11): 156.

https://doi.org/10.1182/blood.V112.11.156.156

Published: 2008

Journal Articles

Adherence to Imatinib Mesylate Treatment: Two Years Follow up

Carlos A. Doti, M.D., German R Stemmelin, M.D., Elena Beatriz Moiraghi, MD, María Gabriela Flores, MD, Juan Garcia, MD, Hector Murro, MD, Eduardo O Bullorsky

Blood (2008) 112 (11): 4267.

https://doi.org/10.1182/blood.V112.11.4267.4267

Published: 2008

Journal Articles

Clinical Outcomes in Patients with Relapsed/Refractory Acute Leukemia Treated with FLAG-IDA Regimen.

Ana L. Basquiera, MD, M. Virginia Prates, MD, Ana Gabriela Sturich, MD, Adriana R. Berretta, MD, Jorge Milone, MD, Juan Garcia, MD

Blood (2006) 108 (11): 4561.

https://doi.org/10.1182/blood.V108.11.4561.4561

Published: 2006

Journal Articles

Monitoring Response to Imatinib by Fluorescence In Situ Hybridization (FISH) and Real-Time Quantitative Polymerase Chain Reaction (RQ-PCR) in Chronic Myeloid Leukemia (CML) Patients in Chronic Phase. Experience of Argentina and Uruguay.

Blood (2006) 108 (11): 4766.

https://doi.org/10.1182/blood.V108.11.4766.4766

Published: 2006

Journal Articles

Graft vs. Tumor Effects (GVT) in Non Myeloablative Stem Cells Transplant (NST) in Relapse Hodgkin Disease (HD) after Autologous Bone Marrow Transplant (ABMT).

Jorge H. Milone, MD, Javier A. Bordone, MD, Gustavo Kusminsky, MD, Cecilia Foncuberta, MD, Juan Garcia, MD, Juliana Martinez Rolon, MD, Eduardo Bullorsky, MD, Cristina Dengra, MD, Ider Cerutti, MD

Blood (2005) 106 (11): 5425.

https://doi.org/10.1182/blood.V106.11.5425.5425

Published: 2005

NARROW

CD70 Deregulation in Follicular Lymphoma at Diagnosis Is Associated with Relapse and Opens New Avenues for Dual CD19-CD70 CAR-T Therapy

From in silico to in Vitro to In Vivo : Increasing Megakaryocytes to Treat Thrombocytopenia

Chimeric Antigen Receptor T Cell Therapies Clinical Trials in Pediatric Oncology: A Retrospective Analysis from Clinicaltrials.Gov

HCT.CI in Autologous Stem Cell Transplantation. Predicting Early and Late Transplant Related Mortality

Is Not Age, But Comorbidities. Allogeneic Hematopoietic Stem Cell Transplantation In Patients Older Than 50 Years In Argentina

Allogeneic Stem Cell Transplantation With Reduced Intensity Conditioning Regimen In Patients With Relapsed Hodgkin´s Lymphoma

Long-Term Disease-Free Survival in Patients with Relapsed/Refractory Follicular Lymphoma After Autologous Stem Cell Trasplantation

Long-Term Experience with Allogeneic Bone Marrow Transplant (BMT) in Chronic Myeloid Leukemia

Argentine Registry of Hematologic Disease (RAEH) Chronics Myeloid Leukemia

Overall Survival by Prognosis Score in High-Risk Myelodysplastic Syndromes (MDS) Patients Receiving Decitabine Treatment: Results From Clinical Experience

Efficacy Analysis From Phase I Study of Lorvotuzumab Mertansine (IMGN901), Used as Monotherapy, In Patients with Heavily Pre-Treated CD56-Positive Multiple Myeloma - A Preliminary Efficacy Analysis

Applicability of a New Prognostic Scoring System in Myelodysplastic Syndromes. MDS Study Group of Hematology.

Decitabine Activity in Myelodysplastic Syndromes. International Cooperative Multi-Center Study.

KIR-Ligand Incompatibility in the Graft-Versus-Host Direction Is Associated with Better Outcomes after Unrelated Cord Blood Stem Cell Transplantation for Acute Leukemia in Complete Remission

Adherence to Imatinib Mesylate Treatment: Two Years Follow up

Clinical Outcomes in Patients with Relapsed/Refractory Acute Leukemia Treated with FLAG-IDA Regimen.

Monitoring Response to Imatinib by Fluorescence In Situ Hybridization (FISH) and Real-Time Quantitative Polymerase Chain Reaction (RQ-PCR) in Chronic Myeloid Leukemia (CML) Patients in Chronic Phase. Experience of Argentina and Uruguay.

Graft vs. Tumor Effects (GVT) in Non Myeloablative Stem Cells Transplant (NST) in Relapse Hodgkin Disease (HD) after Autologous Bone Marrow Transplant (ABMT).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only